The development of new Point-of-Care testing devices continues at a rapid pace. Novel products have improved specimen collection techniques, microprocessor-based analyzers, and are based on novel assay formats. Moreover, the global point of care devices industry rides on a wave of technological advancements for improved size and non-invasive biochemical detection.
New technologies, such as microprocessor-based analyzers and disposable test cartridges containing biosensor-laden silicon tests, have made POCT devices small and portable with minimally invasive techniques. Biosensor based tests offer advantages such as the reduced cost of care with an improved turnaround time. These devices can be used by non-specialists to detect and diagnose diseases, and can enable the selection of optimal therapies through patient screening. Furthermore, new laser-based skin perforators permit the collection of just a few microliters of interstitial fluid for testing glucose levels with infrared sensors to measure glucose and other analytes.
Also, Smartphone "appcessories," devices that connect with a smartphone, are increasing the functionality of POCT’s. This includes devices like BHR's CUBE Point of Care Analyser that performs POCT CRP analysis as well as 9 other tests in less than five minutes, followed by Propeller Health's 'smart' inhalers that connects to asthma sufferers smartphones to log their geolocation, which makes a doctor feasible to monitor the air quality of certain locations or times trigger attacks.